Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria
about
The homogentisate pathway: a central catabolic pathway involved in the degradation of L-phenylalanine, L-tyrosine, and 3-hydroxyphenylacetate in Pseudomonas putida.The interactions in the carboxyl terminus of human 4-hydroxyphenylpyruvate dioxygenase are critical to mediate the conformation of the final helix and the tail to shield the active site for catalysis.4-hydroxyphenylpyruvate dioxygenase catalysis: identification of catalytic residues and production of a hydroxylated intermediate shared with a structurally unrelated enzymeMulti-tissue computational modeling analyzes pathophysiology of type 2 diabetes in MKR mice.NMR-Based Screening for Inborn Errors of Metabolism: Initial Results from a Study on Turkish NeonatesReconstruction and analysis of human kidney-specific metabolic network based on omics data.Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality.A GC/MS-based metabolomic approach for reliable diagnosis of phenylketonuria.Applying Genomic Analysis to Newborn ScreeningGo it alone: four-electron oxidations by mononuclear non-heme iron enzymes.Regulatory pathway analysis of coat color genes in Mongolian horses.Fungal metabolic model for tyrosinemia type 3: molecular characterization of a gene encoding a 4-hydroxy-phenyl pyruvate dioxygenase from Aspergillus nidulans.Expanding the phenotype of hawkinsinuria: new insights from response to N-acetyl-L-cysteine.Biochemical and Clinical Aspects of Hereditary Tyrosinemia Type 1.Molecular insight into the inhibition mechanism of plant and rat 4-hydroxyphenylpyruvate dioxygenase by molecular docking and DFT calculations
P2860
Q29346848-302D4FF4-E7F6-410B-83EE-ECA0CFDE964AQ30352892-5656796A-CADA-44D7-B138-7E8CD9359C96Q30502554-AB11A227-9749-40E5-9BFA-4F3A2AA91B8EQ33910761-CA3DE5B0-32E7-445A-8C4B-FE84CF7E7660Q34457727-1390510B-E4BA-4847-9714-B533B4843156Q35040014-57D8EF1C-221C-4CCB-BC67-89D3A2AEAB9DQ35767753-F8A8D081-7BF6-41F7-A505-9A25C7F95FA8Q35789606-246B6D3F-A91D-4ECB-A805-5A80B941A9D4Q36323604-EF25EA81-E56A-4588-B9CA-5939C3CF871FQ38991287-14D543CD-37D2-4644-A26F-B0302C9FE22FQ41767294-26CA0C3B-9CA1-438F-89D3-5E9177984008Q41949734-B62FC37E-700C-4344-BDB8-9FB7D5478486Q48129049-2202425D-CD0C-4CC6-9175-B56AB62A2B0EQ51817721-04DE24ED-802C-466C-BD54-4F8C74245706Q57963876-3A1DF94B-8202-44A3-B6C9-45A04F8D1192
P2860
Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@ast
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@en
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@nl
type
label
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@ast
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@en
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@nl
prefLabel
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@ast
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@en
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@nl
P2093
P356
P1476
Mutations in the 4-hydroxyphen ...... mia type III and hawkinsinuria
@en
P2093
T Matsuura
P304
P356
10.1006/MGME.2000.3085
P407
P577
2000-11-01T00:00:00Z